BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 10, 2002
View Archived Issues
Elan repositions business for long-term growth
Read More
Genta evaluates Genasense in children with solid tumors
Read More
Paladin seeks marketing approval for Statex SR in Canada
Read More
Pfizer's pregabalin regulatory submission delayed
Read More
AMD-3100 enters phase I trial in cancer patients for stem cell transplantation
Read More
Phase II FluINsure trial completes enrollment
Read More
First filing made for new anticoagulant Exanta
Read More
Weight loss induced by Axokine is maintained for a year after end of treatment
Read More
Combining A-200, ephedrine and caffeine does not enhance weight loss in obese patients
Read More
Bupropion reported to enhance weight loss in dieting patients with depressive symptoms
Read More
Weight-lowering effects of anticonvulsants
Read More
New data support single daily doses of LY-307161 SR to treat type 2 diabetes
Read More
Clinical pharmacokinetic and safety data reported for insulin detemir
Read More
Orally active B-cell IgE synthesis inhibitors discovered by Novartis team
Read More
Sigma-Tau synthesizes phenylalkylcarboxylates with superior profile to rosiglitazone
Read More
CSP-2503: a potent and selective 5-HT1A agonist with anxiolytic activity
Read More
Syk inhibitors synthesized at Novartis as novel therapeutics for asthma
Read More
Potent and selective VR1 antagonist described in recent abstract
Read More
Potential new treatments for chronic bronchitis targeting 15-LO sought by Pfizer
Read More
Active metabolite of caspofungin prepared and tested at Merck
Read More
Prostaglandin analogues for restenosis following PTCA presented by Taisho
Read More
New MMP inhibitors for use in inflammatory disorders
Read More
Prodrugs of kainate receptor modulators with potential in pain and cognition disorders
Read More
New PDE4 inhibitors prepared and tested at Mercian
Read More
PI-88 enters phase I in combination with Taxotere
Read More
Suntory and Daiichi to establish new pharma company
Read More
FDA advisory committee recommends approval of Spiriva
Read More